Document Detail

RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival.
MedLine Citation:
PMID:  22056879     Owner:  NLM     Status:  Publisher    
The concept of cancer stem-like cells (CSCs) has gained considerable attention in various solid tumors including glioblastoma, the most common primary brain tumor. This sub-population of tumor cells has been intensively investigated and their role in therapy resistance as well as tumor recurrence has been demonstrated. In that respect, development of therapeutic strategies that target CSCs (and possibly also the tumor bulk) appears a promising approach in patients suffering from primary brain tumors. In the present study, we utilized RNA interference (RNAi) to screen the complete human kinome and phosphatome (682 and 180 targets, respectively) in order to identify genes and pathways relevant for the survival of brain CSCs and thereby potential therapeutical targets for glioblastoma. We report of 46 putative candidates including known survival-related kinases and phosphatases. Interestingly, a number of genes identified are involved in metabolism, especially glycolysis, such as PDK1 and PKM2 and, most prominently PFKFB4. In vitro studies confirmed an essential role of PFKFB4 in the maintenance of brain CSCs. Furthermore, high PFKFB4 expression was associated with shorter survival of primary glioblastoma patients. Our findings support the importance of the glycolytic pathway in the maintenance of malignant glioma cells and brain CSCs and imply tumor metabolism as a promising therapeutic target in glioblastoma.Oncogene advance online publication, 7 November 2011;doi:10.1038/onc.2011.490.
V Goidts; J Bageritz; L Puccio; S Nakata; M Zapatka; S Barbus; G Toedt; B Campos; A Korshunov; S Momma; E Van Schaftingen; G Reifenberger; C Herold-Mende; P Lichter; B Radlwimmer
Related Documents :
21174279 - Malignant peripheral nerve sheath tumor of the infratemporal fossa with intracranial ex...
11251009 - Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synth...
24469819 - Noninvasive positron emission tomography and fluorescence imaging of cd133+ tumor stem ...
21503829 - Usefulness of (13)n-nh (3) pet in the evaluation of brain lesions that are hypometaboli...
16103069 - Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving ch...
25323469 - Hilar location is an independent prognostic factor for recurrence in t1 renal cell carc...
19198999 - Carcinosarcoma of the gallbladder: report of a case.
6330459 - Utility of the abdominoinguinal incision in the resection of lower abdominal tumors.
22157369 - Detection of egfr mutation status in lung adenocarcinoma specimens with different propo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-07
Journal Detail:
Title:  Oncogene     Volume:  -     ISSN:  1476-5594     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1] Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany [2] Department of Pediatric Oncology, Hematology and Immunology, Children's Hospital, University of Heidelberg, Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with c...
Next Document:  Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory eff...